Cargando…
Insulin-like growth factor-I gene delivery to astrocytes reduces their inflammatory response to lipopolysaccharide
BACKGROUND: Insulin-like growth factor-I (IGF-I) exerts neuroprotective actions in the central nervous system that are mediated at least in part by control of activation of astrocytes. In this study we have assessed the efficacy of exogenous IGF-I and IGF-I gene therapy in reducing the inflammatory...
Autores principales: | Bellini, Maria J, Hereñú, Claudia B, Goya, Rodolfo G, Garcia-Segura, Luis M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056784/ https://www.ncbi.nlm.nih.gov/pubmed/21371294 http://dx.doi.org/10.1186/1742-2094-8-21 |
Ejemplares similares
-
Insulin-like growth factor-I gene therapy reverses morphologic changes and reduces hyperprolactinemia in experimental rat prolactinomas
por: Console, Gloria M, et al.
Publicado: (2008) -
Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide
por: Santos-Galindo, María, et al.
Publicado: (2011) -
Insulin and insulin-like growth factor-I receptors in astrocytes exert different effects on behavior and Alzheimer´s-like pathology
por: Zegarra-Valdivia, Jonathan, et al.
Publicado: (2022) -
Magnetofection Enhances Adenoviral Vector-based Gene Delivery in Skeletal Muscle Cells
por: Pereyra, Andrea Soledad, et al.
Publicado: (2016) -
Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury
por: Genis, Laura, et al.
Publicado: (2014)